期刊文献+

骨转录因子Runx2和骨桥蛋白OPN在人乳腺癌组织中的表达及其与乳腺癌微钙化的关系 被引量:16

The expressions of Runx2 and OPN protein in human breast cancer tissue and their association with microcalcification
下载PDF
导出
摘要 目的观察骨转录因子Runx2、骨桥蛋白(osteopontin,OPN)在人乳腺癌组织中的表达,并进一步探讨其与乳腺癌微钙化形成间的关系。方法利用免疫组化方法观察骨转录因子Runx2和骨桥蛋白OPN在62例乳腺癌组织中的表达。根据乳腺癌患者钼靶X线片中微钙化的有无与数量多少,将62例乳腺癌分为3组,即无钙化组、少量钙化组以及大量钙化组,观察Runx2和OPN蛋白表达与不同乳腺癌微钙化之间的关系。结果 Runx2蛋白在人类乳腺癌组织中表达阳性率为72.6%(45/62)。OPN蛋白在人类乳腺癌组织中表达阳性率为79.0%(49/62)。Runx2和OPN蛋白的阳性表达与乳腺癌钼靶X线片中微钙化的出现和数量密切相关,随着微钙化从无到有以及由少至多,Runx2(χ2=15.686,P<0.05)和OPN(χ2=16.161,P<0.05)蛋白的阳性表达率呈逐步增高的趋势。但Runx2和OPN阳性表达与乳腺癌钼靶片中微钙化形态无关。结论 Runx2和OPN蛋白在人类乳腺癌组织中高表达,其可能参与了乳腺癌微钙化的形成过程。 Objective To explore the expressions of Runx2 and osteopontin (OPN) in human breast cancer tissue and their association with the formation of microcalcification. Methods The expressions of Runx2 and OPN were detected in breast cancer tissue of 62 cases by immunohistochemical method. Then the 62 cases were divided into three groups: non-microcalcification, mild-microcalcification and high-microcalcification groups according to the amount of microcalcification shown on mammography in breast cancer. The association of Runx2 and OPN expressions with microcalcification was further studied. Results The positive expression rate of Runx2 and OPN in human breast cancer tissue was 72.6% and 79.0%, respectively. The positive expression of Runx2 and OPN proteins was significantly correlated with the amount of microcalcification, but not with the morphology of microcalcification in breast cancer tissue. The positive rate of Runx2 and OPN was gradually elevated with the increase in the amount of microcalcification ( X^2 = 15. 686, P〈0.05 ; X^2 = 16. 161, P〈0.05), respectively. Conclusion Runx2 and OPN proteins are highly expressed in human breast cancer tissue and they may participate in the process of microcalcification formation in breast cancer.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第6期828-831,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 陕西省科学技术研究发展计划项目(No.2013K12-03-19)~~
关键词 乳腺癌 RUNX2 骨桥蛋白(OPN) 免疫组化 微钙化 钼靶 breast cancer Runx2 osteopontin (OPN) immunohistochemistry microcalcification molybde- num target
  • 相关文献

参考文献15

  • 1CRAFT M,BICKNELL AM,HAZAN GJ,et al.Microcalcifications detected as an abnormality on screening mammography:outcomes and followup over a five-year period[J].Int J Breast Cancer,2013:458540.
  • 2杨光,张祥宏,张静,张志刚,王晓玲,严霞,王俊灵,赵俊京,李智岗.乳腺癌组织中骨桥蛋白和骨连接蛋白的表达及其与微钙化形成的关系[J].中华放射学杂志,2006,40(9):953-956. 被引量:20
  • 3MARTIN JW,ZIELENSKA M,STEIN GS,et al.The role of RUNX2 in osteosarcoma oncogenesis[J].Sarcoma,2011:282745.
  • 4OLFA G,CHRISTOPHE C,PHILIPPE L,et al.RUNX2 regulates the effects of TNFalpha on proliferation and apoptosis in SaOs-2 cells[J].Bone,2010,46(4):901-910.
  • 5WANG DC,WANG HF,YUAN ZN.Runx2induces bone osteolysis by transcriptional suppression of TSSC1[J].Biochem Biophys Res Commun,2013,438(4):635-639.
  • 6DALLE CARBONARE L,INNAMORATI G,VALENTI MT.Transcription factor Runx2 and its application to bone tissue engineering[J].Stem Cell Rev,2012,8(3):891-897.
  • 7ENDO T,OHTA K,KOBAYASHI T.Expression and function of Cbfa-1/Runx2in thyroid papillary carcinoma cells[J].J Clin Endocrinol Metab,2008,93(6):2409-2412.
  • 8BAE SC,LEE YH.Phosphorylation,acetylation and ubiquitination:the molecular basis of RUNX regulation[J].Gene,2006,366(1):58-66.
  • 9张媛,闫玉仙.Runx2及相关骨科疾病研究进展[J].武警医学院学报,2010,19(11):914-917. 被引量:2
  • 10闵大六,沈赞,林峰,徐晓丽,黄文涛,姚阳.Runx2和Ezrin基因在骨肉瘤组织中的表达及其临床意义[J].中国癌症杂志,2012,22(9):685-689. 被引量:11

二级参考文献64

  • 1邢变枝,毛善平.Galectin-3在人脑星形胶质瘤细胞中的表达[J].卒中与神经疾病,2004,11(6):381-384. 被引量:10
  • 2柴本甫,汤雪明,李慧.实验性骨折愈合中钙化与骨化的超微结构观察(兼论成纤维细胞的成骨作用)[J].中华创伤杂志,1995,11(1):4-6. 被引量:25
  • 3Franceschi RT, Xiao G. Regulation of the osteoblastspecific transcription factor, Runx2: responsiveness to multiple signal transduetion pathways[J]. J Cell Biochem,2003, 88:446-454.
  • 4Vaillant F, Blyth K, Andrew L, Nell JC, Cameron ER. Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection[J]. J Immunol 2002,169:2 866-2 874.
  • 5Barnes GL, Javed A, Waller SM, et al. Osteoblast-related transcription factors Runx2 (Cbfa1/ AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells[J]. Cancer Res, 2003, 63:2631-2637.
  • 6Brubaker KD, Vessella RL, Brown LG, et al. Prostate cancer expression of runt-domain transcription factor Runx2 , a key regulator of osteoblast differentiation and function[J]. Prostate, 2003,56 : 13-22.
  • 7Riminucci M, Corsi A, Peris K, et al. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma[J]. Calcif Tissue Int, 2003,73:281-289.
  • 8Ito Y. Oncogenic potential of the RUNX gene family: overview[J]. Oncogene, 2004,23:4 198-4 208.
  • 9Vaillant F, Blyth K, Andrew L, et al. Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection[J]. J Immunol 2002, 169:2 866-2 874.
  • 10Durst KL, Hiebert SW. Role of RUNX family members in transcriptional repression and gene silencing[J]. Oncogene, 2004,23:4 220-4 224.

共引文献31

同被引文献157

引证文献16

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部